Total Credits: 1 including 1 AOA Category 1-A Credit(s)
Understand vocabulary specific to transgender medicine
Have an understanding of what social transitioning means for the patient
Be able to assist patients in considering the risks and benefits of hormone therapy
Be able to assist patients in considering the risks and benefits of surgery
Understand the importance of an integrated team approach in managing transition
Dr. Safer has no actual or potential conflict of interest in relation to this program or presentation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL 32301, or by email to admin@foma.org
|
Transgender Medicine - An Evidence-Based Approach
(13.1 MB)
Thank you for purchasing this course. |
Available after Purchase | ||
Joshua D. Safer, MD, FACP, FACE is the Executive Director of the Mount Sinai Center for Transgender Medicine and Surgery (CTMS) and Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Safer was previously the founding Medical Director of the Center for Transgender Medicine and Surgery at Boston Medical Center and Boston University School of Medicine. Dr. Safer earned his medical degree from the University of Wisconsin. He completed his internal medicine residency at Mount Sinai Beth Israel and his endocrinology fellowship at Beth Israel Deaconess Medical Center in Boston. Dr. Safer was the inaugural president of the United States Professional Association for Transgender Health (USPATH). He also serves on the Global Education Initiative committee for the World Professional Association for Transgender Health (WPATH) and on the Standards of Care revision committee for WPATH. Dr. Safer was a co-author of the Endocrine Society guidelines for the medical care of transgender patients and has been a scientific co-chair for WPATH's international meetings. In addition, he is a past president of the Association of Specialty Professors, the umbrella organization for leaders in internal medicine subspecialty education, and a former secretary-treasurer of the national endocrinology program director organization, the Association of Program Directors in Endocrinology and Metabolism, (APDEM). Dr. Safer’s research focus is on demonstrating the health and quality of life benefits for transgender patients from increased access to care. His current and past sources of funding support include the NIH and a number of private foundations.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|